Novel implantable bioelectronic treatment delivers immediate, substantial, and sustained reduction in blood pressure Data showed 14.2 mmHg reduction in 24-hour ambulatory systolic blood pressure at three months and 23.4 mmHg reduction in office cuff systolic blood pressure out to two years Therapy applicable to a wide range of hypertensive patients […]
Other News
MEDTRONIC REPORTS FISCAL YEAR AND FOURTH QUARTER 2019 FINANCIAL RESULTS
Q4 Revenue of $8.1 Billion, Flat as Reported and Grew 3.6% Organic Q4 GAAP Diluted EPS of $0.87; Q4 Non-GAAP Diluted EPS of $1.54 FY19 Revenue of $30.6 Billion Grew 2.0% Reported and 5.5% Organic FY19 GAAP Diluted EPS of $3.41; FY19 Non-GAAP Diluted EPS of $5.22 FY19 Cash Flow […]
BioSig Allowed First Key US Patent Claims for its PURE EP™ System
Santa Monica, CA, May 23, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that the US Patent Office allowed 33 patent claims covering its PURE EP™ System. […]
Economic Analysis Shows ACIST CVi™ System Significantly Reduces Costs and Improves Patient Safety for Coronary Catheterizations Compared with Manual Injection
EDEN PRAIRIE, Minn., May 22, 2019 /PRNewswire/ — ACIST Medical Systems, a pioneering interventional and diagnostic technology company with a portfolio of advanced products for the cardiac cath lab, today announced the results of an economic analysis demonstrating the ACIST CVi contrast delivery system significantly reduces costs, increases operational efficiency and improves patient […]
Heart and Vascular Patient Care Expands to Serve Western Colorado and Eastern Utah
GRAND JUNCTION, Colo., May 22, 2019 /PRNewswire/ — SCL Health St. Mary’s Medical Center is pleased to announce the opening of a new $48.5 million, 46,000 square foot Heart & Vascular Institute in Grand Junction, Colorado. The institute brings advanced care and minimally invasive procedures to western Colorado and eastern Utah, such as TAVR/TAVI heart valve implants, other interventional […]
Neovasc Announces Positive Two-Year Follow-up Safety and Efficacy Data for the Neovasc Reducer™ in a Peer Reviewed Article in the International Journal of Cardiology
VANCOUVER, May 22, 2019 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that the International Journal of Cardiology has published a […]
Boston Scientific Initiates Trial Comparing Left Atrial Appendage Closure to Direct Oral Anticoagulants for Stroke Risk Reduction Post-AFib Ablation
MARLBOROUGH, Mass., May 22, 2019 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has initiated the OPTION trial to compare safety and effectiveness of the next-generation WATCHMAN FLX™ left atrial appendage closure (LAAC) platform to first-line oral anticoagulants (OAC) – including direct oral anticoagulants (DOAC) and warfarin – for stroke risk reduction in patients with […]
Sotera Wireless Welcomes New Chief Operating Officer
SAN DIEGO–(BUSINESS WIRE)–Sotera Wireless, maker of the ViSi Mobile® Surveillance Monitoring System and a pioneer in continuous vital signs monitoring, announced today the appointment of veteran engineering and operations executive Younes Achkire, PhD, as its new Chief Operating Officer. With a doctorate from the Free University of Brussels and post-doctorate […]
ClearFlow Names Michael Elniski VP of Global Sales
ANAHEIM, Calif,–(BUSINESS WIRE)–ClearFlow, Inc., a medical device company based in Anaheim, California, has named Michael Elniski its new Vice President of Global Sales. Elniski, who most recently served as Franchise VP of Cardiac Critical Care at Merit Medical and was previously VP of Healthcare Solutions at Edwards Lifesciences, is recognized […]
Results Announced from Two Renal Denervation Studies at EuroPCR Show Positive Outcomes in High-Risk Hypertensive Patients
DUBLIN and PARIS – May 22, 2019 – Investigators today unveiled late-breaking clinical data from a first-of-its-kind physician sponsored clinical trial. The data indicate that renal denervation (RDN) with the Medtronic Symplicity(TM) renal denervation system was associated with reduced occurrence of subclinical atrial fibrillation (AF) in a small subset of high-risk […]
Recent
SCAI and CRT Announce Partnership to Advance Interventional Cardiology Education, Advocacy, and Research
Procyrion Appoints Andrew Davis as Chief Commercial Officer
SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI
Popular
- No commented posts yet